These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 30858145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts.
    Wegner CS, Hauge A, Simonsen TG, Gaustad JV, Andersen LMK, Rofstad EK.
    Neoplasia; 2018 Jul; 20(7):734-744. PubMed ID: 29886124
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
    Ellingsen C, Hompland T, Galappathi K, Mathiesen B, Rofstad EK.
    Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
    Song KD, Choi D, Lee JH, Im GH, Yang J, Kim JH, Lee WJ.
    AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
    [Abstract] [Full Text] [Related]

  • 8. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM, Ellingsen C, Galappathi K, Rofstad EK.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):e121-7. PubMed ID: 22381901
    [Abstract] [Full Text] [Related]

  • 9. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C, Egeland TA, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):838-45. PubMed ID: 19215820
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer.
    Hillestad T, Hompland T, Fjeldbo CS, Skingen VE, Salberg UB, Aarnes EK, Nilsen A, Lund KV, Evensen TS, Kristensen GB, Stokke T, Lyng H.
    Cancer Res; 2020 Sep 15; 80(18):3993-4003. PubMed ID: 32606004
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Monitoring tumour microenvironment changes during anti-angiogenesis therapy using functional MRI.
    Liang J, Cheng Q, Huang J, Ma M, Zhang D, Lei X, Xiao Z, Zhang D, Shi C, Luo L.
    Angiogenesis; 2019 Aug 15; 22(3):457-470. PubMed ID: 31147887
    [Abstract] [Full Text] [Related]

  • 20. [Value of dynamic MRI in monitoring the microenvironmental changes of anti-vascular therapy in a xenograft model].
    Liang JY, Xiao ZY, Zhang D, Ma MJ, Huang JX, Shi CZ, Luo LP.
    Zhonghua Yi Xue Za Zhi; 2020 Jan 07; 100(1):51-56. PubMed ID: 31914559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.